Pharmacokinetics of Hu5F9-G4, a first-in-class anti-CD47 antibody, in patients with solid tumors and lymphomas.

被引：5

作者：

Agoram, Balaji

Wang, Bing

Sikic, Branimir I.

Lakhani, Nehal J.

Patnaik, Amita

Liu, Jie

Secreto, Rochelle

Chao, Mark

Takimoto, Chris H. M.

机构：

[1] Forty Seven Inc, Menlo Pk, CA USA

[2] MedImmune, Mountain View, CA USA

[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[4] START Midwest, Grand Rapids, MI USA

[5] South Texas Accelerated Res Therapeut, San Antonio, TX USA

[6] Stanford Univ, Stanford, CA 94305 USA

[7] Jansen, Menlo Pk, CA USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.2525

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2525

引用

页数：1